peptid
triazol
thiol
ptt
found
previous
bind
env
spike
caus
irrevers
viru
inactiv
shed
lytic
releas
lumin
capsid
protein
sinc
virion
remain
visual
intact
lysi
appear
occur
via
limit
membran
destabil
better
understand
ptttrigger
membran
transform
involv
investig
role
envelop
cholesterol
releas
measur
effect
cholesterol
deplet
use
methyl
betacyclodextrin
unexpect
bellshap
respons
ptt
correspond
induc
lysi
observ
involv
lysi
enhanc
low
vs
loss
function
high
impact
cholesterol
deplet
pttinduc
lysi
revers
ad
exogen
cholesterol
sterol
support
membran
raft
sterol
support
raft
induc
limit
revers
cholesterol
deplet
appear
caus
reduc
energi
barrier
lysi
judg
decreas
temperatur
depend
enhancementreplenish
respons
also
observ
infect
consist
similar
energi
barrier
effect
membran
transform
viru
cell
fusion
overal
result
argu
cholesterol
envelop
import
balanc
viru
stabil
membran
transform
partial
deplet
increas
infect
also
make
viru
fragil
result
also
reinforc
argument
lytic
inactiv
infect
process
mechanist
relat
membran
transform
occur
lysi
provid
experiment
window
investig
membran
protein
factor
import
cell
entri
envelop
viru
lipid
bilay
separ
content
viru
extracellular
milieu
two
virusspecif
surfac
protein
use
entri
protein
form
trimer
heterodim
commonli
denot
viral
spike
env
product
infect
take
place
initi
interact
viral
spike
compon
cellular
receptor
follow
conform
chang
expos
host
cell
membran
follow
interact
fusogen
tip
cell
membran
rearrang
helic
heptad
repeat
region
within
subunit
trimer
form
sixhelix
bundl
latter
bring
viral
cellular
membran
close
proxim
enabl
membran
fusion
turn
fusion
enabl
lumin
content
includ
viru
genom
rna
enter
cell
lead
viru
life
cycl
step
establish
cellular
infect
ultim
product
infecti
viru
membran
fusion
known
critic
viru
cell
entri
infect
membran
transform
event
occur
fusion
fulli
understood
inhibit
entri
previous
identifi
peptid
triazol
class
hiv
entri
inhibitor
bind
inhibit
interact
either
coreceptor
bind
site
conform
entrap
context
spike
trigger
shed
peptid
triazol
thiol
x
ferrocenyl
triazol
prolin
free
thiol
ptt
ctermin
cystein
residu
inhibit
infect
nanomolar
potenc
caus
shed
viru
also
trigger
releas
lumin
thu
ad
along
shed
irrevers
inactiv
viru
cellfre
environ
releas
suggest
abil
ptt
perturb
viral
envelop
without
directli
interact
envelop
lead
loss
membran
integr
lytic
releas
appear
occur
fragment
envelop
rather
limit
membran
transform
sinc
virion
visual
transmiss
electron
microscopi
tem
retain
intact
although
shrunken
physic
state
order
identifi
properti
envelop
control
lytic
inactiv
process
investig
effect
progress
cholesterol
deplet
cholesterol
major
constitu
envelop
membran
bilay
make
mol
evalu
effect
cholesterol
deplet
lysi
pretreat
pseudovirus
methyl
betacyclodextrin
pseudovirus
use
viru
model
studi
entri
process
antagon
provid
viruslik
particl
env
spike
varieti
strain
incorpor
main
differ
model
virus
fulli
infecti
virus
inabl
pseudoviru
produc
fulli
infecti
viral
particl
cell
infect
sinc
genet
code
contain
frame
shift
mutat
importantli
pseudovirus
contain
extra
gene
express
enzym
luciferas
infect
cell
chemiluminesc
chang
upon
substrat
convers
enzym
use
readout
success
infect
strikingli
observ
bellshap
respons
pseudoviru
lysi
progress
increas
includ
enhanc
function
intermedi
even
though
signific
shed
bind
target
ptt
occur
condit
induc
enhanc
lysi
concentr
enhanc
lysi
also
caus
increas
infect
enhanc
effect
lysi
infect
revers
ad
exogen
raftpromot
sterol
differenti
effect
temperatur
lysi
untreat
vs
viru
suggest
decreas
energi
barrier
membran
disrupt
may
respons
parallel
enhanc
effect
lysi
infect
furthermor
enhanc
effect
observ
reminisc
similar
effect
report
previous
influenza
viru
lipid
mix
liposom
fusion
well
infect
suggest
cholesterol
content
provid
balanc
function
stabil
gener
found
envelop
viru
membran
cholestenon
dehydroergosterol
triton
purchas
sigmaaldrich
laurdan
dye
purchas
invitrogen
rabbit
mous
antibodi
purchas
abcam
antibodi
purchas
aalto
solubl
produc
purifi
describ
previous
monoclon
antibodi
obtain
strateg
biosolut
wildtyp
wt
produc
vector
encod
gkpipnpllgldst
code
sequenc
ntermin
ctermin
tag
vector
also
carri
mammalian
codonoptim
sequenc
secret
peptid
gift
dr
navid
madani
joseph
sodroski
dna
transient
transfect
purifi
use
qiagen
maxiprep
kit
qiagen
transfect
hek
cell
accord
manufactur
protocol
invitrogen
five
day
transfect
initi
cell
harvest
spun
supernat
filter
filter
corn
purif
perform
antibodycoupl
column
prepar
use
nhsactiv
sepharos
ge
healthcar
elut
column
use
glycin
buffer
ph
tri
ph
ident
elut
fraction
confirm
sdspage
western
blot
use
antibodi
aalto
bioreag
pool
peak
fraction
addit
purif
includ
remov
aggreg
perform
prepack
superdex
hr
gel
filtrat
chromatographi
column
ge
healthcar
monomercontain
fraction
identifi
sdspagewestern
blot
mab
pool
concentr
frozen
store
peptid
synthes
previosuli
describ
stepwis
solidphas
peptid
synthesi
rink
amid
resin
substitut
valu
mmol
g
novabiochem
fmocamino
acid
deriv
coupl
reagent
purchas
chemimpex
intern
inc
synthesisgrad
solvent
use
procedur
peptid
purifi
homogen
judg
analyt
reversedphas
hplc
integr
purifi
peptid
confirm
malditof
mass
spectrometri
observ
mass
da
vs
da
expect
da
vs
da
peptid
triazol
solubil
pb
ph
absorb
measur
nm
quartz
cuvett
shimadzu
model
spectrophotomet
concentr
determin
use
extinct
coeffici
cm
cm
respect
function
peptid
test
competit
assay
use
surfac
plasmon
reson
spr
analysi
biacor
optic
biosensor
pseudovirus
produc
previous
describ
briefli
hek
cell
cotransfect
plasmid
r
e
luc
core
dna
use
polyethylenimin
pei
transfect
vehicl
jrfl
pseudovirus
produc
ident
manner
pseudovirus
h
supernat
contain
viru
collect
filter
use
filter
corn
purifi
via
gradient
centrifug
iodixanol
gradient
optiprep
sigmaaldrich
spun
ti
rotor
beckman
coulter
g
h
bottom
ml
collect
dilut
serumfre
medium
aliquot
frozen
importantli
virus
isol
iodixanol
gradient
method
found
contain
exosom
judg
absenc
see
figur
support
inform
diagnost
presenc
exosom
virus
report
previous
batch
pseudoviru
titrat
infect
content
immedi
product
treatment
perform
freshli
solubil
powder
pb
treatment
involv
mix
viru
sampl
final
viru
concentr
load
onto
elisa
plate
normal
base
protein
content
ngml
vv
incub
min
lysi
experi
sampl
immedi
treat
ptt
control
except
temperaturedepend
experi
latter
experi
sampl
first
treat
pb
min
move
incub
differ
temperatur
equilibr
min
simultan
solut
contain
ptt
separ
tube
also
equilibr
appropri
temperatur
min
time
point
ptt
ad
viru
mixtur
incub
anoth
min
sampl
spun
test
leak
capsid
protein
assum
michaelismententyp
kinet
zerothord
regim
concentr
exce
bind
affin
mani
order
magnitud
vs
nm
accord
micha
constant
therefor
interpret
amount
detect
min
divid
min
effect
maximum
rate
lysi
plot
natur
logarithm
timeaverag
rate
vs
reciproc
temperatur
made
extract
valu
effect
energi
barrier
slope
calcul
bestfit
line
determin
use
linear
fit
algorithm
provid
origin
pro
shed
experi
pseudoviru
sampl
spun
immedi
min
treatment
h
g
infect
experi
sampl
wash
remov
iodixanol
gradient
centrifug
infect
experi
involv
cholesterol
reconstitut
sampl
treat
min
wash
treat
exogen
cholesterol
anoth
min
fraction
centrifug
gradient
compos
iodixanol
optiprep
sigma
dilut
pb
run
h
spin
g
fraction
collect
test
content
infect
competit
elisa
either
bind
use
rule
effect
function
assay
highbind
elisa
plate
coat
ngwell
solubl
protein
overnight
h
follow
block
step
bsa
pb
sampl
final
nm
coreceptor
surrog
final
nm
mix
vv
bsa
without
load
onto
plate
plate
incub
room
temperatur
h
agit
stain
antihuman
biotinyl
ebiosci
streptavidinhrp
secondari
antibodi
antihuman
igg
conjug
hrp
follow
min
incub
orthophenylenediamin
opd
dissolv
mgml
sodium
citrat
perbor
measur
colorimetr
bound
use
absorb
tecan
infinit
plate
reader
nm
plate
contain
posit
neg
protein
control
provid
window
signal
pseudoviru
supernat
collect
transfect
concentr
sampl
sampl
label
control
proteas
sampl
receiv
u
endoh
enzym
new
england
biolab
dilut
buffer
sampl
flick
promot
mix
incub
min
proteas
sampl
proteinas
k
chymotrypsin
sigmaaldrich
trypsin
cellgro
ad
flick
promot
mix
per
protocol
develop
crook
et
al
control
sampl
match
volum
pb
ad
sampl
incub
min
one
tablet
proteas
inhibitor
complet
mini
roch
germani
dissolv
ml
pb
inhibitor
mix
ad
tube
min
proteas
treatment
sampl
purifi
iodixanol
gradient
describ
pseudoviru
product
sandwich
elisa
perform
describ
previous
briefli
highbind
elisa
plate
corn
coat
ngwell
mous
incub
rocker
overnight
h
antibodi
solut
mix
block
bsa
pb
ph
h
room
temperatur
rocker
plate
wash
briefli
pb
contain
pbst
load
sampl
viru
stock
dilut
pb
ph
contain
ngml
content
final
sampl
load
plate
dilut
viru
mix
pb
vv
invers
incub
min
nonlyt
peptid
pb
neg
control
ad
tube
vv
sampl
mix
invers
incub
anoth
min
ml
tube
spun
h
g
top
supernat
care
remov
disturb
pellet
viru
debri
supernat
dilut
vv
pb
contain
bsa
triton
standard
abcam
ngml
use
everi
assay
buffer
sampl
load
onto
prepar
elisa
plate
plate
incub
overnight
h
rocker
wash
time
pbst
plate
stain
rabbit
primari
antibodi
follow
donkey
antirabbit
hrp
conjug
ge
bioscienc
secondari
antibodi
incub
h
room
temperatur
sequenti
pb
bsa
steadi
agit
plate
wash
addit
opd
plate
develop
min
dark
absorb
measur
nm
determin
endpoint
valu
use
infinit
tecan
plate
reader
pseudovir
infect
assay
carri
describ
previous
use
valid
virus
use
work
track
effect
infect
briefli
cell
seed
previou
day
cell
plate
viru
stock
dilut
growth
media
final
dilut
gave
luminesc
count
cell
seed
previou
day
cell
plate
use
mix
dilut
viru
vv
invers
incub
min
control
mix
equival
amount
pb
sampl
wash
use
iodixanol
gradient
medium
remov
plate
viruscontain
medium
ad
plate
incub
h
medium
chang
forti
eight
hour
h
viru
ad
plate
medium
remov
cell
lyse
passiv
lysi
buffer
promega
lysat
transfer
white
well
plate
greiner
mix
mm
luciferin
salt
anaspec
dilut
potassium
phosphat
buffer
contain
magnesium
sulfat
luminesc
measur
use
wallac
microbeta
luminesc
reader
nm
cholesterol
quantifi
use
previous
establish
enzymat
method
sampl
pseudoviru
treat
differ
amount
rins
thoroughli
pb
prior
quantif
use
enzym
cholesterol
oxidas
horseradish
peroxidas
effici
remov
suffic
base
test
alon
result
background
signal
sampl
viru
mix
cholesterol
oxidas
uml
horseradish
peroxidas
uml
amplex
red
pb
incub
dark
white
well
plate
greiner
min
read
fluoresc
plate
reader
synergi
biotek
exem
nm
quantifi
cholesterol
content
exogen
supplement
cholesterol
sampl
treat
except
wash
step
sampl
treat
exogen
ad
cholesterol
pb
min
purifi
iodixanol
densiti
gradient
treatment
sampl
spun
h
fraction
collect
test
content
determin
locat
pseudoviru
fraction
contain
pseudoviru
wash
use
kda
mwco
amicon
ml
concentr
test
cholesterol
content
well
content
valu
obtain
cholesterol
content
normal
valu
valu
normal
sampl
untreat
pseudoviru
expos
incub
separ
analysi
step
viru
shed
quantif
use
western
blot
shed
induc
alon
pt
present
measur
use
western
blot
describ
previous
briefli
mix
viru
stock
vv
incub
min
spun
h
g
sampl
supernat
mix
laemmli
buffer
boil
min
load
onto
sdspage
gel
gel
electrophoresi
protein
transfer
onto
pvdf
membran
immobilonp
millipor
block
milk
solubil
pb
contain
stain
sheep
aalto
follow
donkey
antisheep
hrp
invitrogen
antibodi
luminol
substrat
advansta
ad
protein
band
expos
chemiluminesc
film
blue
ultra
genem
develop
xomat
processor
kodak
develop
film
scan
correspond
imag
analyz
imagej
nih
densitometri
sampl
pseudoviru
treat
full
rang
incub
min
spun
h
g
supernat
remov
remain
pellet
mix
thoroughli
pipet
fix
sampl
fix
solut
contain
paraformaldehyd
glutaraldehyd
min
fix
quench
use
glycin
fix
viru
sampl
adsorb
overnight
h
elisa
plate
rocker
protein
nih
aid
repositori
also
adsorb
plate
plate
block
bsa
pb
h
stain
sequenti
antibodi
follow
antihuman
hrp
millipor
opd
develop
valu
normal
untreat
viru
control
pb
blank
sterol
reconstitut
perform
use
cholesterol
coprostanol
cholestanol
powder
sampl
solubil
chloroform
dilut
pb
vv
creat
mm
stock
glass
vial
sampl
vortex
thoroughli
creat
milki
emuls
immedi
prior
use
viru
sampl
pretreat
prior
addit
sterol
sterol
incub
pseudoviru
anoth
min
allow
passiv
absorpt
viral
envelop
prior
addit
subsequ
third
incub
step
min
sampl
pellet
centrifug
g
h
supernat
test
capsid
protein
via
sandwich
elisa
intact
viru
sampl
treat
pb
lyse
viru
sampl
treat
triton
pellet
centrifug
form
window
addit
control
includ
individu
sterol
treatment
confirm
nonspecif
lytic
releas
sampl
use
infect
assay
prepar
way
except
rins
serumfre
medium
three
time
min
g
amicon
concentr
kda
mwco
millipor
aliquot
ml
centrifug
tube
cholesterol
serial
dilut
pb
ad
tube
sampl
incub
min
run
iodixanol
gradient
fraction
gradient
ad
cell
plate
rest
protocol
carri
regular
infect
assay
previous
mention
sampl
treat
prior
sterol
treatment
stock
viru
treat
min
ad
ml
centrifug
tube
solut
exogen
cholesterol
coprostanol
cholestanol
serial
dilut
mix
sampl
pseudoviru
tube
invert
mix
sterol
viru
incub
anoth
min
sampl
incub
pb
neg
control
final
min
spun
h
sampl
treat
complet
elisa
viru
sampl
treat
min
wash
thrice
g
min
amicon
concentr
kda
mwco
sampl
fix
solut
contain
paraformaldehyd
glutaraldehyd
min
sampl
wash
mix
osmium
tetroxid
incub
gentl
shake
h
sampl
wash
seven
time
deioniz
water
concentr
volum
load
lacey
carbon
grid
em
microscopi
dri
overnight
imag
sampl
stain
uranyl
acet
rins
imag
perform
transmiss
electron
microscopi
tem
system
jeol
model
kev
membran
fluiditi
probe
use
fluoresc
dye
laurdan
accord
protocol
loriz
et
al
briefli
laurdan
mix
viru
final
concentr
min
wash
use
kda
amicon
ultra
concentr
three
time
g
min
sampl
viru
mix
differ
concentr
min
imag
plate
reader
biotek
synergi
exem
nm
blue
nm
red
fluiditi
calcul
gener
polar
gp
unit
gp
denot
order
domain
gp
denot
disord
membran
follow
formula
use
b
intens
nm
r
intens
nm
pseudovirus
stain
fluoresc
dye
dhe
sigmaaldrich
prefer
liquid
order
raft
phase
membran
dhe
dissolv
chloroform
make
stock
solut
immedi
prior
experi
concentr
dye
measur
methanol
use
ultravioletvis
light
uvvi
absorb
pseudovirus
stain
final
concentr
dehydroergosterol
min
dark
room
temperatur
constant
agit
follow
excess
dye
remov
run
viru
dye
mixtur
desalt
column
ge
treat
min
dark
fluoresc
measur
perform
presenc
potassium
iodid
collision
quencher
ensur
membranebound
dye
remain
fluoresc
verifi
control
experi
dhe
mix
absenc
presenc
ki
rel
fluoresc
measur
see
figur
support
inform
measur
perform
use
synergi
biotek
plate
reader
monochrom
exem
nm
dhe
untreat
viru
use
control
pb
sampl
use
control
data
present
percentag
paper
subject
linear
interpol
equat
control
individu
experi
defin
signal
window
linear
within
signal
window
establish
sigmoid
plot
fit
use
logist
equat
shown
initi
valu
final
valu
x
xvalu
center
sigmoid
p
steep
curv
unpair
test
perform
graphpad
prism
web
interfac
locat
http
wwwgraphpadcomquickcalc
use
paramet
n
sd
mean
investig
role
membran
cholesterol
ptt
trigger
perturb
releas
measur
effect
viru
pretreat
increas
concentr
pseudotyp
virus
first
treat
rang
min
follow
addit
nonlyt
parent
peptid
triazol
rinnixwseammamid
x
ferrocenyl
triazol
prolin
concentr
use
base
ec
valu
first
determin
releas
figur
valu
similar
previous
observ
concentr
use
final
treat
sampl
centrifug
separ
pellet
viru
fraction
releas
solubl
protein
fraction
latter
assay
sandwich
elisa
content
pretreat
sampl
red
circl
figur
show
initi
mark
increas
releas
maximum
follow
steep
declin
higher
concentr
releas
observ
addit
either
pb
alon
black
squar
figur
blue
triangl
figur
indic
enhanc
observ
specif
control
experi
see
figur
support
inform
show
direct
effect
bind
solubl
sinc
high
concentr
previous
report
caus
lysi
evalu
effect
alon
found
dose
caus
releas
figur
black
squar
cholesterol
loss
induc
measur
previous
use
fluorimetr
assay
use
assay
compar
effect
treatment
cholesterol
content
effect
releas
infect
sampl
viru
wash
pb
mix
cocktail
contain
cholesterol
oxidas
horseradish
peroxidas
amplex
red
provid
fluoresc
readout
correspond
cholesterol
content
treatment
pb
alon
use
neg
control
untreat
pseudoviru
use
determin
valu
cholesterol
content
result
shown
figur
confirm
dosedepend
deplet
envelop
cholesterol
content
upon
treatment
midpoint
note
envelop
cholesterol
deplet
incomplet
highest
use
sinc
cholesterol
deplet
found
data
shown
greater
intermedi
concentr
addit
sphingomyelinas
convert
envelop
sphingomyelin
ceramid
possibl
incomplet
remov
cholesterol
could
due
least
part
stabil
sphingomyelincholesterol
interact
membran
also
examin
whether
known
effect
shed
occur
concentr
found
affect
lysi
pseudovirusassoci
examin
use
western
blot
elisa
respect
method
data
obtain
figur
show
releas
residu
viru
dosedepend
manner
midpoint
retain
viru
fraction
sinc
shed
analysi
show
larg
amount
spikeassoci
shed
concentr
lysi
activ
high
consid
like
inact
misfold
spike
select
shed
presenc
inact
spike
confirm
treat
pseudovirus
endo
h
proteolysi
trypsin
chymotrypsin
proteinas
k
use
previous
select
remov
aberr
env
spike
enzymetr
viru
sampl
purifi
iodixanol
gradient
character
infect
chemiluminesc
assay
quantit
western
blot
content
use
sandwich
elisa
viru
quantit
result
pseudoviru
sampl
use
releas
shed
assay
content
decreas
markedli
enzym
treatment
data
shown
infect
virus
affect
data
shown
also
found
previous
importantli
shown
figur
support
inform
enzymetr
virus
exhibit
bellshap
respons
lysi
similar
observ
figur
virus
treat
enzym
evalu
extent
enhanc
effect
cholesterol
deplet
lytic
inactiv
could
revers
addit
exogen
cholesterol
pseudovirus
first
treat
exogen
cholesterol
final
treatment
min
sampl
spun
pellet
viru
supernat
test
content
pb
treatment
substitut
cholesterol
treatment
neg
control
viru
sampl
cholesterol
deplet
result
enhanc
releas
specif
addit
exogen
cholesterol
reduc
observ
enhanc
figur
full
set
cholesterol
replenish
result
obtain
report
figur
support
inform
convers
viru
sampl
cholesterol
deplet
led
suppress
lysi
addit
exogen
cholesterol
led
partial
recoveri
chang
cholesterol
content
pseudoviru
exogen
sterol
addit
provid
figur
support
inform
evalu
extent
sterol
deriv
differ
capac
support
membran
raft
format
would
support
releas
evalu
virus
reconstitut
raftsupport
cholestanol
dehydrocholesterol
nonraftsupport
coprostanol
cholestenon
cholestan
pseudoviru
treat
pb
throughout
experi
use
intact
viru
control
detergenttr
sampl
pseudoviru
use
lyse
control
lysi
observ
occur
sterol
variant
absenc
data
shown
shown
figur
exogen
cholestanol
dehydrocholesterol
revers
effect
cholesterol
deplet
although
derivativeen
recoveri
reduc
compar
cholesterol
contrast
coprostanol
cholestenon
cholestan
induc
much
lower
suppress
lysi
recoveri
expand
dataset
show
sterol
effect
lysi
provid
figur
cholestanol
coprostanol
dehydrocholesterol
cholestenon
cholestan
support
inform
reduc
recoveri
latter
three
sterol
evid
sampl
viru
treat
increas
amount
sterol
figur
support
inform
importantli
result
show
effect
sterol
revers
cholesterol
deplet
effect
lysi
directli
relat
abil
support
raft
format
function
import
cholesterol
raft
viru
infect
previous
report
evalu
morpholog
biophys
transit
result
treatment
affect
lytic
inactiv
untreat
pseudovirus
fix
imag
tem
microscop
jeol
model
viru
imag
untreat
pseudovirion
see
figur
well
figur
support
inform
significantli
differ
averag
size
nm
untreat
vs
nm
vs
nm
respect
n
mean
sd
despit
variat
size
virus
micrograph
along
find
retent
cholesterol
deplet
figur
support
conclus
virion
remain
intact
treatment
absenc
exposur
shown
previous
use
electron
spin
reson
esr
fluoresc
cholesterol
deplet
result
fluid
membran
confirm
vsvg
pseudotyp
virus
use
laurdan
current
studi
figur
importantli
howev
major
shift
fluiditi
observ
high
chang
lower
increas
lysi
complet
figur
evalu
chang
membran
sterol
environ
previous
develop
fluoresc
assay
use
dehydroergosterol
dhe
sterol
preferenti
local
raftlik
region
treat
dhe
fluoresc
emiss
decreas
start
fluoresc
minimum
emiss
intens
increas
figur
experi
perform
presenc
potassium
iodid
quench
dhe
extract
membran
verifi
observ
decreas
intens
shown
figur
henc
fluoresc
measur
taken
reflect
membran
incorpor
dhe
surmis
decreas
trend
fluoresc
might
due
remov
nonraft
associ
dhe
beyond
threshold
alter
environ
form
around
dhe
still
embed
within
viral
membran
might
occur
high
consequ
greatli
reduc
cholesterol
lead
dissolut
membran
raft
turn
raft
disrupt
could
allow
fluoresc
sterol
later
diffus
within
viral
envelop
greater
distanc
dye
molecul
becom
dequench
importantli
invert
bellshap
curv
dhe
fluoresc
suggest
membran
transform
occur
rang
enhanc
lysi
infect
ask
whether
cholesterol
deplet
might
lower
energi
barrier
membran
lysi
lytic
inactiv
found
previous
requir
bundl
format
transform
like
involv
travers
energi
barrier
lower
energi
barrier
lysi
could
explain
greater
lytic
releas
occur
increas
even
though
content
bind
target
decreas
sampl
contain
equal
amount
pseudoviru
treat
pb
control
min
transfer
incub
differ
temperatur
temperatureequilibr
pbscontain
mix
sampl
incub
anoth
min
sampl
spun
content
fraction
contain
releas
protein
measur
use
sandwich
elisa
data
provid
figur
support
inform
analysi
data
show
two
trend
natur
logarithm
total
amount
lysi
linearli
relat
invers
temperatur
suggest
arrheniuslik
barriermedi
process
neg
slope
ln
vs
greater
sampl
without
treatment
compar
sampl
treatment
suggest
treatment
lower
barrier
similar
data
obtain
experi
lower
concentr
figur
show
differ
temperatur
respons
consist
observ
differ
extent
lytic
reaction
data
consist
hypothesi
activ
energi
lysi
reduc
pretreat
enhanc
lytic
inactiv
treatment
observ
current
work
similar
prior
find
enhanc
infect
correl
suggest
common
effect
cholesterol
deplet
viru
membran
transform
event
occur
viru
membran
lysi
induc
peptid
triazol
thiol
viruscel
membran
fusion
occur
infect
sought
confirm
find
infect
enhanc
virus
use
current
lysi
studi
sampl
pseudotyp
virus
treat
pb
control
wash
ad
cell
express
receptor
pseudoviru
infect
inde
enhanc
condit
caus
lysi
enhanc
see
figur
expand
analysi
infect
vs
concentr
show
sensit
enhanc
zone
suppress
zone
provid
figur
support
inform
infect
chang
observ
cholesterol
replenish
similar
sterol
support
raft
format
cholestanol
sterol
support
raft
coprostanol
cholestenon
cholestan
induc
signific
differ
sampl
treat
alon
see
figur
similar
treatment
perform
virus
without
pseudotyp
spike
contain
capsid
core
coat
lipid
bilay
neither
lysi
infect
observ
dose
rang
examin
data
shown
treatment
perform
virusfre
cell
wash
addit
untreat
virus
chang
infect
observ
data
shown
note
infect
enhanc
also
observ
current
work
jrfl
tier
less
easili
neutral
strain
vs
laboratoryadapt
strain
pseudotyp
vs
respect
see
figur
variabl
extent
infect
enhanc
observ
latter
virus
fit
prior
find
moresubdu
enhanc
effect
report
pseudotyp
virus
lai
addit
exogen
cholesterol
found
previous
revers
effect
infect
caus
cholesterol
deplet
investig
whether
enhanc
infect
upon
partial
cholesterol
deplet
low
could
revers
replenish
differ
sterol
experi
analog
describ
lytic
inactiv
revers
pseudoviru
sampl
first
treat
pb
wash
solubl
viru
mix
cholesterol
fraction
use
iodixanol
gradient
viru
fraction
collect
cell
infect
activ
measur
normal
content
infect
measur
peak
fraction
report
figur
lytic
inactiv
activ
infect
decreas
substanti
compar
magnitud
shown
viru
without
ad
cholesterol
current
investig
undertaken
evalu
role
membran
cholesterol
deplet
previous
observ
potent
specif
lytic
inactiv
peptid
triazol
thiol
bind
trigger
releas
lumin
prior
work
alreadi
shown
largescal
cholesterol
deplet
high
concentr
caus
disrupt
inactiv
judg
shed
loss
cell
infect
activ
observ
similar
loss
lytic
inactiv
activ
high
howev
importantli
found
lowtointermedi
instead
caus
signific
enhanc
lytic
inactiv
figur
enhanc
effect
visual
occur
sensit
viru
membran
transform
occur
dose
rang
substanti
cholesterol
deplet
shed
occur
see
figur
effect
lysi
revers
ad
cholesterol
concentr
caus
lytic
enhanc
also
affect
membran
lipid
bilay
organ
figur
fluiditi
figur
judg
use
membraneincorpor
fluorophor
dehydroergosterol
vs
laurdan
enhanc
lysi
partial
cholesterol
deplet
may
relat
decreas
energi
barrier
membran
transform
judg
reduc
slope
rate
lysi
pretreat
vs
without
pretreat
rang
temperatur
see
figur
accord
prior
find
result
obtain
work
argu
cholesterol
deplet
effect
lysi
infect
specif
like
due
alter
viru
membran
abil
reconstitut
function
phenotyp
untreat
viru
sterol
replenish
treatment
demonstr
effect
revers
depend
mainli
sterol
content
viru
membran
extent
regain
phenotyp
upon
replenish
depend
extent
replenish
sterol
support
raft
format
consist
previous
observ
import
raft
viru
infect
directli
measur
amount
replenish
differ
sterol
deriv
prior
publish
result
demonstr
rel
minor
variabl
passiv
incorpor
sterol
type
use
allow
correl
current
work
sterol
type
lysisinfect
enhanc
furthermor
confirm
viru
fraction
use
work
fulli
deplet
protein
see
figur
support
inform
henc
contain
exosom
could
confound
monitor
biochem
effect
due
nonspecif
releas
upon
treatment
fact
effect
observ
work
due
specif
chang
membran
order
fit
observ
correl
enhanc
chang
fluoresc
report
dhe
incorpor
viru
envelop
membran
compar
figur
figur
enhanc
pttinduc
lysi
concentr
caus
env
shed
paradox
env
protein
need
ptt
bind
importantli
retent
infect
previous
shown
toler
reduc
produc
either
enzymat
remov
inact
spike
lower
incorpor
trimer
recombin
viru
still
extent
shed
induc
lysisenhanc
concentr
substanti
one
possibl
explan
paradox
reduct
lysi
due
loss
counterbalanc
reduct
energi
barrier
lytic
transform
viru
particl
explan
support
observ
decreas
slope
lysistemperatur
depend
relationship
viru
pretreat
figur
viru
spike
known
metast
receptor
bind
env
abl
drive
cascad
conform
transit
lead
high
energi
env
unligand
state
residu
low
energi
form
form
bundl
deplet
cholesterol
could
lower
energi
barrier
bundl
format
found
previous
compon
entri
infect
process
also
lysi
process
may
occur
cholesterol
act
stabil
agent
membranespan
protein
form
raft
structur
directli
bind
protein
interact
crac
domain
observ
adrenerg
receptor
serotonin
receptor
oxytocin
receptor
importantli
contain
crac
domain
fact
exist
cholesterol
content
nativ
viru
result
sensit
state
spike
noteworthi
current
work
argu
deplet
cholesterol
would
result
unstabl
env
spike
would
vulner
ligandinduc
rearrang
shed
perturb
associ
membran
henc
cholesterol
content
found
nativ
viru
strike
balanc
stabil
transform
viru
spike
depict
figur
found
work
enhanc
ligandinduc
viru
lysi
intermedi
cholesterol
deplet
correl
infect
enhanc
phenomenon
observ
previous
amplifi
current
studi
extent
dose
depend
sterol
replenish
similar
lysi
infect
note
magnitud
infect
enhanc
previous
report
occur
elev
lower
observ
current
studi
quantit
differ
extent
infect
enhanc
prior
work
may
due
use
differ
virus
shown
differ
jrfl
pseudotyp
figur
vs
figur
lysi
discuss
infect
enhanc
concentr
decreas
amount
present
paradox
increas
function
face
decreas
env
spike
requir
function
envis
lower
energi
barrier
effect
found
lysi
would
also
explain
increas
infect
viru
contain
reduc
consist
previous
observ
find
lysi
infect
mechanist
similar
includ
role
bundl
format
process
result
argu
cholesterol
stabil
viru
surviv
increas
infect
cholesterol
deplet
come
cost
lower
stabil
henc
decreas
surviv
relationship
depict
figur
observ
made
current
work
cholesterol
deplet
trigger
chang
membran
properti
lead
either
function
enhanc
suppress
depend
extent
deplet
relat
type
envelop
virus
includ
influenza
ebola
dengu
high
cholesterol
content
depend
membran
transform
mechan
effect
viruscel
membran
fusion
cellular
infect
exampl
bellshap
effect
cholesterol
deplet
biophys
properti
liposom
fusion
content
mix
rate
influenza
viru
report
henc
defin
natur
membran
transform
occur
enhanc
function
caus
cholesterol
deplet
includ
transform
associ
env
spike
protein
could
help
improv
gener
understand
fusion
mechan
type
virus
studi
also
could
help
understand
natur
membran
transform
trigger
env
protein
ligand
turn
lytic
ligand
could
serv
prototyp
defin
strategi
viru
neutral
har
vulner
envelop
viru
membran
refer
web
version
pubm
central
supplementari
materi
biochem
chang
pseudovirus
caus
treatment
chang
envelop
cholesterol
content
normal
untreat
envelop
follow
treatment
cholesterol
measur
fluorometr
amplex
red
n
mean
sd
b
quantif
spike
protein
retain
treatment
black
squar
assay
supernat
retain
red
circl
assay
viru
pellet
fraction
n
n
mean
sd
effect
cholesterol
deplet
cell
infect
revers
sterol
reconstitut
revers
infect
effect
examin
compar
pseudovirus
treat
either
pb
follow
exogen
cholesterol
cholestanol
dehydrocholesterol
coprostanol
cholestenon
cholestan
incub
min
follow
addit
pb
exogen
cholesterol
incub
min
sampl
final
load
iodixanol
gradient
pb
spun
h
g
fraction
test
infect
content
infect
normal
valu
peak
fraction
valu
report
p
p
p
n
mean
sd
rational
envelop
cholesterol
content
help
strike
balanc
stabil
spike
higher
cholesterol
content
transform
lower
cholesterol
content
